Pancreatic Cancer Research

Preprint2022

Transcriptional landscapes and signaling pathways of LDHA inhibitor treated pancreatic ductal adenocarcinoma

Published
17 August 2022
Citations
0
Type
Preprint

These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.

Try

Source text

abstract license unknown

Lactate dehydrogenase (LDHA) is a metabolism-related enzyme that is involved in the progression of several cancers such as pancreatic ductal adenocarcinoma (PDAC). However, the mechanism of LDHA regulates the PDAC is largely unknown. … Excerpt only: this text is the publisher’s. Read it in full at the source.